Cargando…

Role of FGF23 in Pediatric Hypercalciuria

BACKGROUND: This study explored the possible role of FGF23 in pediatric hypercalciuria. METHODS: Plasma FGF23 was measured in 29 controls and 58 children and adolescents with hypercalciuria: 24 before treatment (Pre-Treated) and 34 after 6 months of treatment (Treated). Hypercalciuric patients also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreira Guimarães Penido, Maria Goretti, de Sousa Tavares, Marcelo, Saggie Alon, Uri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804327/ https://www.ncbi.nlm.nih.gov/pubmed/29457024 http://dx.doi.org/10.1155/2017/3781525

Ejemplares similares

Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents?
por: Penido, Maria Goretti Moreira Guimarães, et al.
Publicado: (2021)

Beyond kidney stones: Why pediatricians should worry about hypercalciuria
por: Penido, Maria Goretti Moreira Guimarães, et al.
Publicado: (2021)

American and Brazilian Children With Primary Urolithiasis: Similarities and Disparities
por: Penido, Maria Goretti Moreira Guimarães, et al.
Publicado: (2014)

Prevalence of risk factors for cardiovascular and kidney disease in Brazilian healthy preschool children
por: da Silva, Adriana Cândida, et al.
Publicado: (2016)

Pathophysiology of hypercalciuria in children
por: Srivastava, Tarak, et al.
Publicado: (2007)

Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria
por: Velazquez-Navarro, Jassel A, et al.
Publicado: (2022)

Phosphate homeostasis and its role in bone health
por: Penido, Maria Goretti M. G., et al.
Publicado: (2012)

Medullary nephrocalcinosis in idiopathic hypercalciuria
por: Koratala, Abhilash, et al.
Publicado: (2017)

FGF-23 Levels before and after Renal Transplantation
por: Economidou, Domniki, et al.
Publicado: (2009)

Serum NGAL and FGF23 may have certain value in early diagnosis of CIN
por: Li, Huihui, et al.
Publicado: (2018)

Mutations in CLDN2 Are Not a Common Cause of Pediatric Idiopathic Hypercalciuria in Canada
por: Ulrich, Emma H., et al.
Publicado: (2022)

The role of salt abuse on risk for hypercalciuria
por: Damasio, Patrícia CG, et al.
Publicado: (2011)

Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
por: Muras-Szwedziak, Katarzyna, et al.
Publicado: (2023)

Correction: The role of salt abuse on risk for hypercalciuria
por: Damasio, Patrícia Capuzzo Garcia, et al.
Publicado: (2011)

Recommendations Of The Brazilian Society Of Nephrology Regarding Pediatric Patients On Renal Replacement Therapy During The Covid-19 Pandemic
por: Tavares, Marcelo de Sousa, et al.
Publicado: (2020)

IgA vasculitis in children
por: Penido, Maria Goretti Moreira Guimarães, et al.
Publicado: (2022)

Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis
por: Schoelwer, Melissa J., et al.
Publicado: (2017)

Vitamin D, Hypercalciuria and Kidney Stones
por: Letavernier, Emmanuel, et al.
Publicado: (2018)

Disseminated Paracoccidioidomycosis in a Kidney Transplant Recipient
por: Felipe, Carlos Rafael A, et al.
Publicado: (2021)

Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis
por: García‐Castaño, Alejandro, et al.
Publicado: (2020)

Is there any correlation between hypercalciuria and nocturnal enuresis?
por: Nikibakhsh, A., et al.
Publicado: (2012)

Hypercalciuria following ceftriaxone a fact or myth
por: Azarfar, Anoush, et al.
Publicado: (2015)

Evaluation of hypercalciuria in patients receiving intravenous Cefotaxime
por: Kalantari, Zahra, et al.
Publicado: (2019)

Familial Hypomagnesemia, Hypercalciuria and Nephrocalcinosis with Novel Mutation
por: Margabandhu, S., et al.
Publicado: (2019)

Evaluation of the Role of FGF23 in Mineral Metabolism
por: Yokota, Hiroki, et al.
Publicado: (2009)

Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility
por: Cameli, Paolo, et al.
Publicado: (2020)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
por: Hartley, Iris R., et al.
Publicado: (2022)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

The prevalence of hypercalciuria in girl kids with over active bladder
por: Yousefichaijan, Parsa, et al.
Publicado: (2015)

Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics
por: Claverie-Martin, Felix
Publicado: (2015)

Renal leak; mechanism of hypercalciuria in short-term immobilization
por: Malaki, Majid
Publicado: (2015)

Effect of Salt Intervention on Serum Levels of Fibroblast Growth Factor 23 (FGF23) in Chinese Adults: An Intervention Study
por: Hu, Jia-Wen, et al.
Publicado: (2018)

Hypercalciuria and Nephrocalcinosis as Early Feature of Wilson Disease Onset: Description of a Pediatric Case and Literature Review
por: Di Stefano, Valeria, et al.
Publicado: (2012)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

FGF23 as a calciotropic hormone
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2015)

Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria
por: Aliberti, Ludovica, et al.
Publicado: (2022)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3h0dqe2chvotiophi9tjg6gjje